Japan’s Toray Develops Biochip For 15-Minute Disease Detection
This article was originally published in PharmAsia News
Executive Summary
Toray Industries says it has developed a device that can cut the time for detecting the presence of cancer or other diseases from days to 15 minutes. Toray said its protein biochip, for which it plans to file an approval application by the end of the fiscal year, is capable of analyzing a single drop of blood for the presence of a disease. The company relied on nanotechnology to create a chip the size of a business card containing a tube for the blood, which can be read by an analyzer. (Click here for more - a subscription may be required
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.